D-1515-2019 Class II Terminated

Recalled by Ascend Laboratories LLC — Parsippany, NJ

FDA drug recall D-1515-2019 was initiated by Ascend Laboratories LLC on Jul 19, 2019 and is designated Class II. Reason for recall: Failed Dissolution Specifications The recall status is terminated (terminated Jun 7, 2021). Affected quantity: a) 5,472 bottles and b) 5,880 bottles.

Recall details

Product Type
Drugs
Report Date
Jul 31, 2019
Initiation Date
Jul 19, 2019
Termination Date
Jun 7, 2021
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
a) 5,472 bottles and b) 5,880 bottles

Product description

Atorvastatin Calcium Tablet USP 80 mg, a) 90 count (NDC 67877-0514-90) and b) 500 count (NDC 67877-0514-05) bottles, Rx only, Manufactured by: Alkem Laboratories, Ltd, Mumbai INDIA, Distributed by: Ascend Laboratories, LLC, Parsippany, NJ

Reason for recall

Failed Dissolution Specifications

Distribution pattern

Product was shipped to wholesalers throughout the United States.

Code information

a) Lot# 19140443, exp. date 12/2020, Lot# 19140525, 19140535, exp. date 01/2021 and b) Lot# 19140756, exp. date 12/2020, Lot# 19140757, Lot# 19140758, exp. date 01/2021, Lot# 19141696, Lot# 19141793, exp. date 03/2021

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-1515-2019
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-1515-2019. Report a data issue: hello@regdatalab.com.